The global End-Stage Renal Disease (ESRD) Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report aims to provide a comprehensive presentation of the global market for End-Stage Renal Disease (ESRD) Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding End-Stage Renal Disease (ESRD) Drugs. This report contains market size and forecasts of End-Stage Renal Disease (ESRD) Drugs in global, including the following market information:
Global End-Stage Renal Disease (ESRD) Drugs Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global End-Stage Renal Disease (ESRD) Drugs Market Sales, 2018-2023, 2024-2032, (K Pcs)
Global top five End-Stage Renal Disease (ESRD) Drugs companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Calcium Succinate Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of End-Stage Renal Disease (ESRD) Drugs include CTI BioPharma Corp, Merck & Co Inc, Novartis AG, Prolong Pharmaceuticals LLC and VESSL Therapeutics Ltd, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the End-Stage Renal Disease (ESRD) Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global End-Stage Renal Disease (ESRD) Drugs Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (K Pcs)
Global End-Stage Renal Disease (ESRD) Drugs Market Segment Percentages, by Type, 2022 (%)
- Calcium Succinate
- Mk-3866
- Pacritinib
- Sanguinate
- Tesidolumab
- Others
Global End-Stage Renal Disease (ESRD) Drugs Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (K Pcs)
Global End-Stage Renal Disease (ESRD) Drugs Market Segment Percentages, by Application, 2022 (%)
- Hospital
- Clinic
- ICU
- Others
Global End-Stage Renal Disease (ESRD) Drugs Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (K Pcs)
Global End-Stage Renal Disease (ESRD) Drugs Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies End-Stage Renal Disease (ESRD) Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies End-Stage Renal Disease (ESRD) Drugs revenues share in global market, 2022 (%)
- Key companies End-Stage Renal Disease (ESRD) Drugs sales in global market, 2018-2023 (Estimated), (K Pcs)
- Key companies End-Stage Renal Disease (ESRD) Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- CTI BioPharma Corp
- Merck & Co Inc
- Novartis AG
- Prolong Pharmaceuticals LLC
- VESSL Therapeutics Ltd
Outline of Major Chapters:
Chapter 1: Introduces the definition of End-Stage Renal Disease (ESRD) Drugs, market overview.
Chapter 2: Global End-Stage Renal Disease (ESRD) Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of End-Stage Renal Disease (ESRD) Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of End-Stage Renal Disease (ESRD) Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global End-Stage Renal Disease (ESRD) Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 End-Stage Renal Disease (ESRD) Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global End-Stage Renal Disease (ESRD) Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global End-Stage Renal Disease (ESRD) Drugs Overall Market Size
2.1 Global End-Stage Renal Disease (ESRD) Drugs Market Size: 2022 VS 2030
2.2 Global End-Stage Renal Disease (ESRD) Drugs Revenue, Prospects & Forecasts: 2018-2030
2.3 Global End-Stage Renal Disease (ESRD) Drugs Sales: 2018-2030
3 Company Landscape
3.1 Top End-Stage Renal Disease (ESRD) Drugs Players in Global Market
3.2 Top Global End-Stage Renal Disease (ESRD) Drugs Companies Ranked by Revenue
3.3 Global End-Stage Renal Disease (ESRD) Drugs Revenue by Companies
3.4 Global End-Stage Renal Disease (ESRD) Drugs Sales by Companies
3.5 Global End-Stage Renal Disease (ESRD) Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 End-Stage Renal Disease (ESRD) Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers End-Stage Renal Disease (ESRD) Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 End-Stage Renal Disease (ESRD) Drugs Players in Global Market
3.8.1 List of Global Tier 1 End-Stage Renal Disease (ESRD) Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 End-Stage Renal Disease (ESRD) Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global End-Stage Renal Disease (ESRD) Drugs Market Size Markets, 2022 & 2030
4.1.2 Calcium Succinate
4.1.3 Mk-3866
4.1.4 Pacritinib
4.1.5 Sanguinate
4.1.6 Tesidolumab
4.1.7 Others
4.2 By Type - Global End-Stage Renal Disease (ESRD) Drugs Revenue & Forecasts
4.2.1 By Type - Global End-Stage Renal Disease (ESRD) Drugs Revenue, 2018-2023
4.2.2 By Type - Global End-Stage Renal Disease (ESRD) Drugs Revenue, 2024-2030
4.2.3 By Type - Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share, 2018-2030
4.3 By Type - Global End-Stage Renal Disease (ESRD) Drugs Sales & Forecasts
4.3.1 By Type - Global End-Stage Renal Disease (ESRD) Drugs Sales, 2018-2023
4.3.2 By Type - Global End-Stage Renal Disease (ESRD) Drugs Sales, 2024-2030
4.3.3 By Type - Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share, 2018-2030
4.4 By Type - Global End-Stage Renal Disease (ESRD) Drugs Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global End-Stage Renal Disease (ESRD) Drugs Market Size, 2022 & 2030
5.1.2 Hospital
5.1.3 Clinic
5.1.4 ICU
5.1.5 Others
5.2 By Application - Global End-Stage Renal Disease (ESRD) Drugs Revenue & Forecasts
5.2.1 By Application - Global End-Stage Renal Disease (ESRD) Drugs Revenue, 2018-2023
5.2.2 By Application - Global End-Stage Renal Disease (ESRD) Drugs Revenue, 2024-2030
5.2.3 By Application - Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share, 2018-2030
5.3 By Application - Global End-Stage Renal Disease (ESRD) Drugs Sales & Forecasts
5.3.1 By Application - Global End-Stage Renal Disease (ESRD) Drugs Sales, 2018-2023
5.3.2 By Application - Global End-Stage Renal Disease (ESRD) Drugs Sales, 2024-2030
5.3.3 By Application - Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share, 2018-2030
5.4 By Application - Global End-Stage Renal Disease (ESRD) Drugs Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global End-Stage Renal Disease (ESRD) Drugs Market Size, 2022 & 2030
6.2 By Region - Global End-Stage Renal Disease (ESRD) Drugs Revenue & Forecasts
6.2.1 By Region - Global End-Stage Renal Disease (ESRD) Drugs Revenue, 2018-2023
6.2.2 By Region - Global End-Stage Renal Disease (ESRD) Drugs Revenue, 2024-2030
6.2.3 By Region - Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share, 2018-2030
6.3 By Region - Global End-Stage Renal Disease (ESRD) Drugs Sales & Forecasts
6.3.1 By Region - Global End-Stage Renal Disease (ESRD) Drugs Sales, 2018-2023
6.3.2 By Region - Global End-Stage Renal Disease (ESRD) Drugs Sales, 2024-2030
6.3.3 By Region - Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America End-Stage Renal Disease (ESRD) Drugs Revenue, 2018-2030
6.4.2 By Country - North America End-Stage Renal Disease (ESRD) Drugs Sales, 2018-2030
6.4.3 US End-Stage Renal Disease (ESRD) Drugs Market Size, 2018-2030
6.4.4 Canada End-Stage Renal Disease (ESRD) Drugs Market Size, 2018-2030
6.4.5 Mexico End-Stage Renal Disease (ESRD) Drugs Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe End-Stage Renal Disease (ESRD) Drugs Revenue, 2018-2030
6.5.2 By Country - Europe End-Stage Renal Disease (ESRD) Drugs Sales, 2018-2030
6.5.3 Germany End-Stage Renal Disease (ESRD) Drugs Market Size, 2018-2030
6.5.4 France End-Stage Renal Disease (ESRD) Drugs Market Size, 2018-2030
6.5.5 U.K. End-Stage Renal Disease (ESRD) Drugs Market Size, 2018-2030
6.5.6 Italy End-Stage Renal Disease (ESRD) Drugs Market Size, 2018-2030
6.5.7 Russia End-Stage Renal Disease (ESRD) Drugs Market Size, 2018-2030
6.5.8 Nordic Countries End-Stage Renal Disease (ESRD) Drugs Market Size, 2018-2030
6.5.9 Benelux End-Stage Renal Disease (ESRD) Drugs Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia End-Stage Renal Disease (ESRD) Drugs Revenue, 2018-2030
6.6.2 By Region - Asia End-Stage Renal Disease (ESRD) Drugs Sales, 2018-2030
6.6.3 China End-Stage Renal Disease (ESRD) Drugs Market Size, 2018-2030
6.6.4 Japan End-Stage Renal Disease (ESRD) Drugs Market Size, 2018-2030
6.6.5 South Korea End-Stage Renal Disease (ESRD) Drugs Market Size, 2018-2030
6.6.6 Southeast Asia End-Stage Renal Disease (ESRD) Drugs Market Size, 2018-2030
6.6.7 India End-Stage Renal Disease (ESRD) Drugs Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America End-Stage Renal Disease (ESRD) Drugs Revenue, 2018-2030
6.7.2 By Country - South America End-Stage Renal Disease (ESRD) Drugs Sales, 2018-2030
6.7.3 Brazil End-Stage Renal Disease (ESRD) Drugs Market Size, 2018-2030
6.7.4 Argentina End-Stage Renal Disease (ESRD) Drugs Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa End-Stage Renal Disease (ESRD) Drugs Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa End-Stage Renal Disease (ESRD) Drugs Sales, 2018-2030
6.8.3 Turkey End-Stage Renal Disease (ESRD) Drugs Market Size, 2018-2030
6.8.4 Israel End-Stage Renal Disease (ESRD) Drugs Market Size, 2018-2030
6.8.5 Saudi Arabia End-Stage Renal Disease (ESRD) Drugs Market Size, 2018-2030
6.8.6 UAE End-Stage Renal Disease (ESRD) Drugs Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 CTI BioPharma Corp
7.1.1 CTI BioPharma Corp Company Summary
7.1.2 CTI BioPharma Corp Business Overview
7.1.3 CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Major Product Offerings
7.1.4 CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Sales and Revenue in Global (2018-2023)
7.1.5 CTI BioPharma Corp Key News & Latest Developments
7.2 Merck & Co Inc
7.2.1 Merck & Co Inc Company Summary
7.2.2 Merck & Co Inc Business Overview
7.2.3 Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Major Product Offerings
7.2.4 Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Merck & Co Inc Key News & Latest Developments
7.3 Novartis AG
7.3.1 Novartis AG Company Summary
7.3.2 Novartis AG Business Overview
7.3.3 Novartis AG End-Stage Renal Disease (ESRD) Drugs Major Product Offerings
7.3.4 Novartis AG End-Stage Renal Disease (ESRD) Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Novartis AG Key News & Latest Developments
7.4 Prolong Pharmaceuticals LLC
7.4.1 Prolong Pharmaceuticals LLC Company Summary
7.4.2 Prolong Pharmaceuticals LLC Business Overview
7.4.3 Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Major Product Offerings
7.4.4 Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Prolong Pharmaceuticals LLC Key News & Latest Developments
7.5 VESSL Therapeutics Ltd
7.5.1 VESSL Therapeutics Ltd Company Summary
7.5.2 VESSL Therapeutics Ltd Business Overview
7.5.3 VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Major Product Offerings
7.5.4 VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Sales and Revenue in Global (2018-2023)
7.5.5 VESSL Therapeutics Ltd Key News & Latest Developments
8 Global End-Stage Renal Disease (ESRD) Drugs Production Capacity, Analysis
8.1 Global End-Stage Renal Disease (ESRD) Drugs Production Capacity, 2018-2030
8.2 End-Stage Renal Disease (ESRD) Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global End-Stage Renal Disease (ESRD) Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 End-Stage Renal Disease (ESRD) Drugs Supply Chain Analysis
10.1 End-Stage Renal Disease (ESRD) Drugs Industry Value Chain
10.2 End-Stage Renal Disease (ESRD) Drugs Upstream Market
10.3 End-Stage Renal Disease (ESRD) Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 End-Stage Renal Disease (ESRD) Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of End-Stage Renal Disease (ESRD) Drugs in Global Market
Table 2. Top End-Stage Renal Disease (ESRD) Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global End-Stage Renal Disease (ESRD) Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global End-Stage Renal Disease (ESRD) Drugs Revenue Share by Companies, 2018-2023
Table 5. Global End-Stage Renal Disease (ESRD) Drugs Sales by Companies, (K Pcs), 2018-2023
Table 6. Global End-Stage Renal Disease (ESRD) Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers End-Stage Renal Disease (ESRD) Drugs Price (2018-2023) & (USD/Pcs)
Table 8. Global Manufacturers End-Stage Renal Disease (ESRD) Drugs Product Type
Table 9. List of Global Tier 1 End-Stage Renal Disease (ESRD) Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 End-Stage Renal Disease (ESRD) Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global End-Stage Renal Disease (ESRD) Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global End-Stage Renal Disease (ESRD) Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global End-Stage Renal Disease (ESRD) Drugs Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs), 2018-2023
Table 15. By Type - Global End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs), 2024-2030
Table 16. By Application ? Global End-Stage Renal Disease (ESRD) Drugs Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global End-Stage Renal Disease (ESRD) Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global End-Stage Renal Disease (ESRD) Drugs Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs), 2018-2023
Table 20. By Application - Global End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs), 2024-2030
Table 21. By Region ? Global End-Stage Renal Disease (ESRD) Drugs Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global End-Stage Renal Disease (ESRD) Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global End-Stage Renal Disease (ESRD) Drugs Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs), 2018-2023
Table 25. By Region - Global End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs), 2024-2030
Table 26. By Country - North America End-Stage Renal Disease (ESRD) Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America End-Stage Renal Disease (ESRD) Drugs Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America End-Stage Renal Disease (ESRD) Drugs Sales, (K Pcs), 2018-2023
Table 29. By Country - North America End-Stage Renal Disease (ESRD) Drugs Sales, (K Pcs), 2024-2030
Table 30. By Country - Europe End-Stage Renal Disease (ESRD) Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe End-Stage Renal Disease (ESRD) Drugs Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe End-Stage Renal Disease (ESRD) Drugs Sales, (K Pcs), 2018-2023
Table 33. By Country - Europe End-Stage Renal Disease (ESRD) Drugs Sales, (K Pcs), 2024-2030
Table 34. By Region - Asia End-Stage Renal Disease (ESRD) Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia End-Stage Renal Disease (ESRD) Drugs Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia End-Stage Renal Disease (ESRD) Drugs Sales, (K Pcs), 2018-2023
Table 37. By Region - Asia End-Stage Renal Disease (ESRD) Drugs Sales, (K Pcs), 2024-2030
Table 38. By Country - South America End-Stage Renal Disease (ESRD) Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America End-Stage Renal Disease (ESRD) Drugs Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America End-Stage Renal Disease (ESRD) Drugs Sales, (K Pcs), 2018-2023
Table 41. By Country - South America End-Stage Renal Disease (ESRD) Drugs Sales, (K Pcs), 2024-2030
Table 42. By Country - Middle East & Africa End-Stage Renal Disease (ESRD) Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa End-Stage Renal Disease (ESRD) Drugs Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa End-Stage Renal Disease (ESRD) Drugs Sales, (K Pcs), 2018-2023
Table 45. By Country - Middle East & Africa End-Stage Renal Disease (ESRD) Drugs Sales, (K Pcs), 2024-2030
Table 46. CTI BioPharma Corp Company Summary
Table 47. CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Product Offerings
Table 48. CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 49. CTI BioPharma Corp Key News & Latest Developments
Table 50. Merck & Co Inc Company Summary
Table 51. Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Product Offerings
Table 52. Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 53. Merck & Co Inc Key News & Latest Developments
Table 54. Novartis AG Company Summary
Table 55. Novartis AG End-Stage Renal Disease (ESRD) Drugs Product Offerings
Table 56. Novartis AG End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 57. Novartis AG Key News & Latest Developments
Table 58. Prolong Pharmaceuticals LLC Company Summary
Table 59. Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Product Offerings
Table 60. Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 61. Prolong Pharmaceuticals LLC Key News & Latest Developments
Table 62. VESSL Therapeutics Ltd Company Summary
Table 63. VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Product Offerings
Table 64. VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 65. VESSL Therapeutics Ltd Key News & Latest Developments
Table 66. End-Stage Renal Disease (ESRD) Drugs Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2021-2023 (K Pcs)
Table 67. Global End-Stage Renal Disease (ESRD) Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 68. Global End-Stage Renal Disease (ESRD) Drugs Production by Region, 2018-2023 (K Pcs)
Table 69. Global End-Stage Renal Disease (ESRD) Drugs Production by Region, 2024-2030 (K Pcs)
Table 70. End-Stage Renal Disease (ESRD) Drugs Market Opportunities & Trends in Global Market
Table 71. End-Stage Renal Disease (ESRD) Drugs Market Drivers in Global Market
Table 72. End-Stage Renal Disease (ESRD) Drugs Market Restraints in Global Market
Table 73. End-Stage Renal Disease (ESRD) Drugs Raw Materials
Table 74. End-Stage Renal Disease (ESRD) Drugs Raw Materials Suppliers in Global Market
Table 75. Typical End-Stage Renal Disease (ESRD) Drugs Downstream
Table 76. End-Stage Renal Disease (ESRD) Drugs Downstream Clients in Global Market
Table 77. End-Stage Renal Disease (ESRD) Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. End-Stage Renal Disease (ESRD) Drugs Segment by Type in 2022
Figure 2. End-Stage Renal Disease (ESRD) Drugs Segment by Application in 2022
Figure 3. Global End-Stage Renal Disease (ESRD) Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global End-Stage Renal Disease (ESRD) Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global End-Stage Renal Disease (ESRD) Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. End-Stage Renal Disease (ESRD) Drugs Sales in Global Market: 2018-2030 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by End-Stage Renal Disease (ESRD) Drugs Revenue in 2022
Figure 9. By Type - Global End-Stage Renal Disease (ESRD) Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share, 2018-2030
Figure 11. By Type - Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share, 2018-2030
Figure 12. By Type - Global End-Stage Renal Disease (ESRD) Drugs Price (USD/Pcs), 2018-2030
Figure 13. By Application - Global End-Stage Renal Disease (ESRD) Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share, 2018-2030
Figure 15. By Application - Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share, 2018-2030
Figure 16. By Application - Global End-Stage Renal Disease (ESRD) Drugs Price (USD/Pcs), 2018-2030
Figure 17. By Region - Global End-Stage Renal Disease (ESRD) Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share, 2018-2030
Figure 20. By Region - Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share, 2018-2030
Figure 21. By Country - North America End-Stage Renal Disease (ESRD) Drugs Revenue Market Share, 2018-2030
Figure 22. By Country - North America End-Stage Renal Disease (ESRD) Drugs Sales Market Share, 2018-2030
Figure 23. US End-Stage Renal Disease (ESRD) Drugs Revenue, (US$, Mn), 2018-2030
Figure 24. Canada End-Stage Renal Disease (ESRD) Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico End-Stage Renal Disease (ESRD) Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe End-Stage Renal Disease (ESRD) Drugs Revenue Market Share, 2018-2030
Figure 27. By Country - Europe End-Stage Renal Disease (ESRD) Drugs Sales Market Share, 2018-2030
Figure 28. Germany End-Stage Renal Disease (ESRD) Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. France End-Stage Renal Disease (ESRD) Drugs Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. End-Stage Renal Disease (ESRD) Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Italy End-Stage Renal Disease (ESRD) Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. Russia End-Stage Renal Disease (ESRD) Drugs Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries End-Stage Renal Disease (ESRD) Drugs Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux End-Stage Renal Disease (ESRD) Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia End-Stage Renal Disease (ESRD) Drugs Revenue Market Share, 2018-2030
Figure 36. By Region - Asia End-Stage Renal Disease (ESRD) Drugs Sales Market Share, 2018-2030
Figure 37. China End-Stage Renal Disease (ESRD) Drugs Revenue, (US$, Mn), 2018-2030
Figure 38. Japan End-Stage Renal Disease (ESRD) Drugs Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea End-Stage Renal Disease (ESRD) Drugs Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia End-Stage Renal Disease (ESRD) Drugs Revenue, (US$, Mn), 2018-2030
Figure 41. India End-Stage Renal Disease (ESRD) Drugs Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America End-Stage Renal Disease (ESRD) Drugs Revenue Market Share, 2018-2030
Figure 43. By Country - South America End-Stage Renal Disease (ESRD) Drugs Sales Market Share, 2018-2030
Figure 44. Brazil End-Stage Renal Disease (ESRD) Drugs Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina End-Stage Renal Disease (ESRD) Drugs Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa End-Stage Renal Disease (ESRD) Drugs Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa End-Stage Renal Disease (ESRD) Drugs Sales Market Share, 2018-2030
Figure 48. Turkey End-Stage Renal Disease (ESRD) Drugs Revenue, (US$, Mn), 2018-2030
Figure 49. Israel End-Stage Renal Disease (ESRD) Drugs Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia End-Stage Renal Disease (ESRD) Drugs Revenue, (US$, Mn), 2018-2030
Figure 51. UAE End-Stage Renal Disease (ESRD) Drugs Revenue, (US$, Mn), 2018-2030
Figure 52. Global End-Stage Renal Disease (ESRD) Drugs Production Capacity (K Pcs), 2018-2030
Figure 53. The Percentage of Production End-Stage Renal Disease (ESRD) Drugs by Region, 2022 VS 2030
Figure 54. End-Stage Renal Disease (ESRD) Drugs Industry Value Chain
Figure 55. Marketing Channels
